The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing Manufacture Of Chemicals And Pharamceuticals Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations 21.10 - Manufacture of basic pharmaceutical products
New offshoring locations
Austria
220 jobs Number of planned job losses
Announcement Date
30 May 2023
Employment effect (start)
1 July 2023
Foreseen end date
31 December 2023
Description
Pharmaceutical company Lek from Slovenia, a subsidiary of Swiss-based Sandoz group, has made a final decision to cease antibiotic production at its Prevalje plant by late 2023, offshoring production to Austria which will lead to the dismissal of 220 workers. As part of the social plan, the company has offered the reemployment of some redundant workers in other LEK plants, and negotiations with the relevant trade union over the redundancy package has begun.
The first relocation announcement was made in 2019 (Lek-2019-SI), but it was then postponed due to the Covid-19 pandemic.
Eurofound (2023), Lek, Offshoring/Delocalisation in Slovenia, factsheet number 109263, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/109263.
Digitisation and automation technologies, including artificial intelligence (AI), can affect working conditions in a variety of ways and their use in the workplace raises a host of new ethical concerns.
The retail banking sector is fertile ground for studying the impacts of digitalisation on work and employment. Financial services are increasingly provided online, without the intermediary of customer-facing institutions.
European labour markets have recovered strongly from COVID-19. By the end of 2021, little more than 18 months after the start of the pandemic, employment rates in the EU were almost at pre-crisis levels.
